Skip to main content
Premium Trial:

Request an Annual Quote

MRA, Hidary Foundation Provide $1M for Acral Melanoma Genomics

NEW YORK (GenomeWeb News) – The Melanoma Research Alliance and the Hidary Foundation have awarded $1 million to fund two new genome sequencing-focused research projects aimed at understanding the genetic drivers of acral melanoma, MRA said today.

The funding will support studies at the Kaiser Permanente Research Institute, Memorial Sloan-Kettering Cancer Center, the Translational Genomics Research Institute, the University of California, San Francisco, and Vanderbilt University.

Acral melanoma is a subtype that generally affects the palms of hands, soles of feet, and underneath fingernails, and has a 10 to 20 percent lower survival rate than non-acral cutaneous melanoma.

"Despite recent progress in defining the genetic basis of cutaneous melanoma, comprehensive studies are lacking in patients with acral melanoma," David Solit, of MSKCC and chairman of MRA's Grant Review Committee, said in a statement.

Hidary Foundation Chairman Jack Hidary said the funding partners believe that whole exome and whole genome sequencing of large sets of patients offers the "key to new breakthroughs in the fight against cancer."

"These teams will focus on unraveling the genetic signature of this cancer, and this will extend their work to other cancers as we collectively build greater genomic capabilities," Hidary said.

Kaiser Permanente's Maryam Asgari will lead one of the research projects, a partnership with UCSF, and the second team will be led by Vanderbilt University's Jeffrey Sosman and will include researchers at MSKCC and TGen.

MRA said it has now awarded over $49 million to support research to find ways to treat, prevent, detect, and stage melanoma.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.